| Mepha Pharma AG - Ropinirol-Mepha retard 4 mg, Retardtabletten | | 62614 | | 02 | | Ropinirol-Mepha retard 4 mg | | Retardtabletten | | N04BC04 | | Ropinirole | | 18.06.2013 | | |
| | Composition | | ropinirolum 4 mg ut ropiniroli hydrochloridum, ammonio methacrylatis copolymerum B, hypromellosum, natrii laurilsulfas, copovidonum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, E 110 0.81 mg, E 132, E 171, pro compresso obducto corresp. natrium 1.077 mg. | | Packungsbestandteile | | Delayed release tablets | | | | | Active Agent | Dose |
|---|
| Ropinirol | 4 mg |
| | BAG: Active Agent | Dose |
|---|
| Ropinirol | 4 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Ammonio Methacrylatis Copolymerum B | | | | Copovidonum | | | | E 110 | 0.81 mg | color. | | E 132 | | color. | | E 171 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Pro Compresso Obducto | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 28 Tablet(s) | 28.72 | 47.65 | B | SL | Yes |
|
|
